COLOSIMO, SANTO
COLOSIMO, SANTO
Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente
Self-efficacy measured through the italian diabetes management self-efficacy scale (IT-DMSES) in individuals with type 2 diabetes
2026 S. Colosimo, A. Guerrini Usubini, S.P. Mambrini, G. Amodeo, A. Sartorio, G. Castelnuovo, S. Bertoli
Training pathways and formal curricula in robotic bariatric surgery: a systematic review
2026 F. Brucchi, D. Zhang, S. Bertoli, S. Colosimo, G. Dionigi
Bariatric Surgery Outcomes in an Italian Single-Center Study: Does Chronotype Matter?
2026 F. Sileo, S. Colosimo, A. Bruno, A. Gambetti, F. Frattini, R. De Amicis, F. Barbera, A. Gotti, V. Vincenti, L. Inì, R. Cancello, M. Croci, M. Novelli, A. Leone, G. Dionigi, A. Battezzati, S. Bertoli
Dysregulated eating phenotypes as predictors of weight loss during Very Low-Energy Ketogenic Therapies in obesity
2026 S. Gallosti, R. De Amicis, A. Bruno, M. Bulzomì, A. Leone, F. Menichetti, S. Colosimo, A. Battezzati, S. Bertoli
Satisfaction About Preoperative Information Regarding Bariatric Surgery: A Single Center Survey
2025 F. Frattini, S. Bertoli, A. Bruno, M. Novelli, S. Colosimo, R. Cancello, A. Gambetti, G. Dionigi, G. Sarro
Gender Differences in Weight Loss Extent Following Bariatric Surgery
2025 S. Colosimo, F. Sileo, A. Gambetti, F. Frattini, A. Bruno, S. Mambrini, L. Gilardini, F. Barbera, A. Gotti, V. Vincenti, L. Inì, M. Novelli, R. Cancello, G. Dionigi, S. Bertoli
Effectiveness of a Digital Therapy on 6-Month Weight Loss in People With Obesity: The Digital Therapy to Promote Weight Loss in Patients With Obesity by Increasing Their Adherence to Treatment (DEMETRA) Randomized Clinical Trial
2025 S. Bertoli, P. Capodaglio, S. Colosimo, R.S. De Amicis, L. Gilardini, A. Bruno, S.P. Mambrini, G. Pietrabissa, L. Cavaggioni, G. Castelnuovo, G. Piazzolla
Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility
2024 S.P. Mambrini, A. Grillo, S. Colosimo, F. Zarpellon, G. Pozzi, D. Furlan, G. Amodeo, S. Bertoli
Metformin and the liver: unlocking the full therapeutic potential
2024 F. Perazza, L. Leoni, S. Colosimo, A. Musio, G. Bocedi, M. D'Avino, G. Agnelli, A. Nicastri, C. Rossetti, F. Sacilotto, G. Marchesini, M.L. Petroni, F. Ravaioli
Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD
2024 S. Colosimo, H. Miller, D.A. Koutoukidis, T. Marjot, G.D. Tan, D.J. Harman, G.P. Aithal, P. Manousou, R. Forlano, R. Parker, D.A. Sheridan, P.N. Newsome, W. Alazawi, J.F. Cobbold, J.W. Tomlinson
Editorial: should NAFLD be included in the definition of Metabolic Syndrome?
2023 S. Colosimo, G. Marchesini
Supplementation with Anti-inflammatory Nutraceutical Products in the Management of Chronic Pelvic Pain: A Narrative Review
2022 S. Colosimo, E. Balzani, R.M. Cioni, M. Campesato, A.F.G. Cicero
Glucose Control in Post-hemolytic-Uremic Syndrome Diabetes: A New Approach Offered by Sensor-Augmented Pump Therapy
2022 V. Grancini, F.A. Vianello, S. Colosimo, A. Gaglio, V. Resi, M. Arosio, G. Ardissino, G. Montini, E. Orsi
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis
2021 S. Colosimo, F. Ravaioli, M.L. Petroni, L. Brodosi, F. Marchignoli, F.A. Barbanti, A.S. Sasdelli, G. Marchesini, L. Pironi